These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 27842480)

  • 1. Mesenchymal Stem Cells as a Source of Dopaminergic Neurons: A Potential Cell Based Therapy for Parkinson's Disease.
    Venkatesh K; Sen D
    Curr Stem Cell Res Ther; 2017; 12(4):326-347. PubMed ID: 27842480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of stem cells in regenerative medicine for Parkinson's and Huntington's Diseases.
    Lescaudron L; Naveilhan P; Neveu I
    Curr Med Chem; 2012; 19(35):6018-35. PubMed ID: 22963567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation and Characterization of Dopaminergic Neurons From Baboon Induced Pluripotent Stem Cells.
    Grow DA; Simmons DV; Gomez JA; Wanat MJ; McCarrey JR; Paladini CA; Navara CS
    Stem Cells Transl Med; 2016 Sep; 5(9):1133-44. PubMed ID: 27343168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipose-derived human mesenchymal stem cells induce long-term neurogenic and anti-inflammatory effects and improve cognitive but not motor performance in a rat model of Parkinson's disease.
    Schwerk A; Altschüler J; Roch M; Gossen M; Winter C; Berg J; Kurtz A; Akyüz L; Steiner B
    Regen Med; 2015 May; 10(4):431-46. PubMed ID: 26022763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.
    Chen W; Huang Q; Ma S; Li M
    ACS Chem Neurosci; 2019 Feb; 10(2):839-851. PubMed ID: 30346716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic differentiation of neural progenitors derived from placental mesenchymal stem cells in the brains of Parkinson's disease model rats and alleviation of asymmetric rotational behavior.
    Park S; Kim E; Koh SE; Maeng S; Lee WD; Lim J; Shim I; Lee YJ
    Brain Res; 2012 Jul; 1466():158-66. PubMed ID: 22634376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.
    Chang YL; Chen SJ; Kao CL; Hung SC; Ding DC; Yu CC; Chen YJ; Ku HH; Lin CP; Lee KH; Chen YC; Wang JJ; Hsu CC; Chen LK; Li HY; Chiou SH
    Cell Transplant; 2012; 21(1):313-32. PubMed ID: 21669041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cells and neuroregeneration in Parkinson's disease.
    Glavaski-Joksimovic A; Bohn MC
    Exp Neurol; 2013 Sep; 247():25-38. PubMed ID: 23542820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct conversion of human umbilical cord mesenchymal stem cells into dopaminergic neurons for Parkinson's disease treatment.
    Liu J; Ji Z; He Q; Chen H; Xu X; Mei Q; Hu Y; Zhang H
    Neurobiol Dis; 2024 Oct; 201():106683. PubMed ID: 39343249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of functional dopaminergic neurons from human spermatogonial stem cells to rescue parkinsonian phenotypes.
    Yang H; Hao D; Liu C; Huang D; Chen B; Fan H; Liu C; Zhang L; Zhang Q; An J; Zhao J
    Stem Cell Res Ther; 2019 Jun; 10(1):195. PubMed ID: 31248447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heat shock protein 60 affects behavioral improvement in a rat model of Parkinson's disease grafted with human umbilical cord mesenchymal stem cell-derived dopaminergic-like neurons.
    Zhao C; Li H; Zhao XJ; Liu ZX; Zhou P; Liu Y; Feng MJ
    Neurochem Res; 2016 Jun; 41(6):1238-49. PubMed ID: 26758268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracarotid Infusion of Mesenchymal Stem Cells in an Animal Model of Parkinson's Disease, Focusing on Cell Distribution and Neuroprotective and Behavioral Effects.
    Cerri S; Greco R; Levandis G; Ghezzi C; Mangione AS; Fuzzati-Armentero MT; Bonizzi A; Avanzini MA; Maccario R; Blandini F
    Stem Cells Transl Med; 2015 Sep; 4(9):1073-85. PubMed ID: 26198165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Differentiation of Midbrain Dopaminergic Neuron: From Bench to Bedside.
    Wang M; Ling KH; Tan JJ; Lu CB
    Cells; 2020 Jun; 9(6):. PubMed ID: 32570916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease.
    Levy YS; Bahat-Stroomza M; Barzilay R; Burshtein A; Bulvik S; Barhum Y; Panet H; Melamed E; Offen D
    Cytotherapy; 2008; 10(4):340-52. PubMed ID: 18574767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic precursors differentiated from human blood-derived induced neural stem cells improve symptoms of a mouse Parkinson's disease model.
    Yuan Y; Tang X; Bai YF; Wang S; An J; Wu Y; Xu ZD; Zhang YA; Chen Z
    Theranostics; 2018; 8(17):4679-4694. PubMed ID: 30279731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cells augment neurogenesis in the subventricular zone and enhance differentiation of neural precursor cells into dopaminergic neurons in the substantia nigra of a parkinsonian model.
    Park HJ; Shin JY; Lee BR; Kim HO; Lee PH
    Cell Transplant; 2012; 21(8):1629-40. PubMed ID: 22546197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human iPSC-derived midbrain organoids functionally integrate into striatum circuits and restore motor function in a mouse model of Parkinson's disease.
    Zheng X; Han D; Liu W; Wang X; Pan N; Wang Y; Chen Z
    Theranostics; 2023; 13(8):2673-2692. PubMed ID: 37215566
    [No Abstract]   [Full Text] [Related]  

  • 18. Cell therapy for Parkinson's disease: Functional role of the host immune response on survival and differentiation of dopaminergic neuroblasts.
    Wenker SD; Leal MC; Farías MI; Zeng X; Pitossi FJ
    Brain Res; 2016 May; 1638(Pt A):15-29. PubMed ID: 26239914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TREM2 gene induces differentiation of induced pluripotent stem cells into dopaminergic neurons and promotes neuronal repair via TGF-β activation in 6-OHDA-lesioned mouse model of Parkinson's disease.
    Liang H; Liu P; Wang Z; Xiong H; Yin C; Zhao D; Wu C; Chen L
    CNS Neurosci Ther; 2024 Feb; 30(2):e14630. PubMed ID: 38348765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and criteria of embryonic stem and induced pluripotent stem cells for a dopamine replacement therapy.
    Cooper O; Parmar M; Isacson O
    Prog Brain Res; 2012; 200():265-76. PubMed ID: 23195423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.